Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Deutsche Bank analyst Jan Koch downgraded Qiagen N.V. (NYSE:QGEN) from Buy to Hold and raised the price target from $52 to $54. Qiagen shares closed at $55.66 on Wednesday. See how other analysts view this stock.
- TD Cowen analyst Yaron Werber downgraded Legend Biotech Corp (NASDAQ:LEGN) from Buy to Hold and cut the price target from $62 to $21. Legend Biotech shares closed at $20.76 on Wednesday. See how other analysts view this stock.
- Keybanc analyst Ashley Owens downgraded Crocs Inc (NASDAQ:CROX) from Overweight to Sector Weight. Crocs shares closed at $85.27 on Wednesday. See how other analysts view this stock.
- Piper Sandler analyst David Westenberg downgraded Zoetis Inc (NYSE:ZTS) from Overweight to Neutral and lowered the price target from $190 to $135. Zoetis shares closed at $125.08 on Wednesday. See how other analysts view this stock.
Considering buying ZTS stock? Here’s what analysts think:
Photo via Shutterstock
Recent Comments